Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Monday, December 28, 2015
Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide
Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment